A drugmaker’s feud with the DEA is exacerbating the ADHD meds crisis — at a rate of 600 million missing doses a year.

A drugmaker’s feud with the DEA is exacerbating the ADHD meds crisis — at a rate of 600 million missing doses a year.

  • nickwitha_k (he/him)@lemmy.sdf.org
    3·
    9 months ago

    Methamphetamine and amphetamine are quite different things. The extra methyl group, while a tiny change, causes significant alterations in how it interacts with the brain’s dopamine signaling. This is also hypothesized to be involved in the greater likelihood of addiction seen in meth.

    • bramblepatchmystery@slrpnk.net
      1·
      9 months ago

      If we assume that people with ADHD are impervious to amphetamine addiction (as we were told) but have higher rates of methyl addiction, as I think you are insinuating, that’s actually a very great argument for not introducing amphetamines to people with ADHD.

      I’m not saying some of us don’t benefit from ADHD, I just think there are other options now in the market that aren’t turning 11 year old children into bona fide drug addicts.